Literature DB >> 23312809

Idiopathic membranous nephropathy: back to the future?

Piero Ruggenenti1, Giuseppe Remuzzi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23312809     DOI: 10.1016/S0140-6736(12)62033-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Treatment of membranous nephropathy: time for a paradigm shift.

Authors:  Piero Ruggenenti; Fernando C Fervenza; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

2.  Glomerular disease: An RCT of treatment for idiopathic membranous nephropathy.

Authors:  Susan J Allison
Journal:  Nat Rev Nephrol       Date:  2013-01-29       Impact factor: 28.314

Review 3.  Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.

Authors:  Agnieszka Pozdzik; Isabelle Brochériou; Cristina David; Fahd Touzani; Jean Michel Goujon; Karl Martin Wissing
Journal:  Biomed Res Int       Date:  2018-01-08       Impact factor: 3.411

4.  Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.

Authors:  Anneke P Bech; Julia M Hofstra; Paul E Brenchley; Jack F M Wetzels
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237

5.  Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population.

Authors:  Shujun Lin; Hong-Yan Li; Tianbiao Zhou; Wenshan Lin
Journal:  Drug Des Devel Ther       Date:  2019-07-11       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.